Denosumab Versus Risedronate in Glucocorticoid-Induced Osteoporosis: Final Results of a Twenty-Four-Month Randomized, Double-Blind, Double-Dummy Trial. [electronic resource]
Producer: 20200106Description: 1174-1184 p. digitalISSN:- 2326-5205
- Absorptiometry, Photon
- Aged
- Bone Density
- Bone Density Conservation Agents -- therapeutic use
- Bone Remodeling
- Collagen Type I -- metabolism
- Denosumab -- therapeutic use
- Double-Blind Method
- Female
- Femur Neck -- diagnostic imaging
- Glucocorticoids -- adverse effects
- Hip -- diagnostic imaging
- Humans
- Lumbar Vertebrae -- diagnostic imaging
- Male
- Middle Aged
- Osteoporosis -- chemically induced
- Osteoporotic Fractures -- prevention & control
- Peptide Fragments -- metabolism
- Peptides -- metabolism
- Procollagen -- metabolism
- Risedronic Acid -- therapeutic use
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial, Phase III; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.